Marker Therapeutics, Inc.

Daily Archives: Wednesday, May 30, 2018

TapImmune to Present at 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum

TapImmune today announced that its President and CEO, Peter Hoang, will participate in a panel discussion and give a company presentation at the 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum, held June 1, 2018, at the Waldorf Astoria Chicago Hotel.
Read More